Cycrimine
Cycrimine (trade name Pagitane) is a central anticholinergic drug designed to reduce the levels of acetylcholine in the treatment of Parkinson's disease. Its mechanism of action is to bind to the muscarinic acetylcholine receptor M1.[1]
![]() | |
Clinical data | |
---|---|
License data |
|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.000.932 ![]() |
Chemical and physical data | |
Formula | C19H29NO |
Molar mass | 287.447 g·mol−1 |
3D model (JSmol) | |
| |
|
Synthesis
![](../I/m/Cycrimine_synthesis.png)
Cycrimine synthesis:[2]
gollark: That sounds kind of dangerous.
gollark: Spirit's already sort of a local meme.
gollark: If you want "somewhat cursed", how about this?
gollark: You should probably have a lot of backups.
gollark: That's cool. I would have expected you'd need some sort of digital circuitry to do that.
See also
References
- Psychotropic Drugs and Related Compounds, 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972, page 218
- Denton, J. J.; Schedl, H. P.; Lawson, Virginia A.; Neier, W. B. (1950). "Antispasmodics. VII.1 Additional Morpholinyl and Piperidyl Tertiary Alcohols". Journal of the American Chemical Society. 72 (8): 3795–3796. doi:10.1021/ja01164a127.
External links
- Cycrimine at DrugLib.com
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.